Sector ratings Novartis AG

Equities

Market Closed - Swiss Exchange Other stock markets 11:31:55 2025-12-08 am EST			5-day change	1st Jan Change
106.64 ^CHF	-0.41%		+2.28%	+20.23%

02:29am	AlphaValue/Baader Europe Ups Novartis Price Target on 'Strong' Execution, 'Vigorous' Growth	MT
02:01am	NOVARTIS AG : Upgraded to Buy by JP Morgan	ZD

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
NOVARTIS AG	255B		AAA
ELI LILLY AND COMPANY	905B		A
JOHNSON & JOHNSON	487B		BBB
ABBVIE INC.	400B		AA
ROCHE HOLDING AG	330B		AA
ASTRAZENECA PLC	281B		A
MERCK & CO., INC.	248B		A
NOVO NORDISK A/S	214B		A
AMGEN INC.	178B		A
GILEAD SCIENCES, INC.	150B		AAA
PFIZER INC.	148B		BBB
SANOFI	120B		A
VERTEX PHARMACEUTICALS INCORPORATED	116B		AA
BRISTOL-MYERS SQUIBB COMPANY	106B		A
GSK PLC	96.56B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	87.18B		AA
ALLERGAN PLC	63.66B	-	-	-	-	-	-	-
ALNYLAM PHARMACEUTICALS, INC.	60.52B		AA	-
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	57.93B		AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	44.82B		AA
Average	217.38B		AA
Weighted average by Cap.			AA